Oncopharmpod
BRAF V600E Updates
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:16:30
- Mas informaciones
Informações:
Sinopsis
Encorafenib + binimetinib gets FDA-approval for metastatic NSCLC, but how does it compare to dabrafenib/trametinib? Plus, a new pediatric approval for dabrafenib/trametinib means more dosage form options.
